Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26083181 | 0.90 | CYP2D6 (0.40) | SLC18A2CYP2D6GAAHTTLMNA | |
| SCHEMBL26083179 | 0.79 | SLC18A2 (0.37) | SLC18A2GAA | |
| SCHEMBL21908618 | 0.78 | GAA (0.44) | SLC18A2GAAHTT | |
| SCHEMBL26083030 | 0.77 | CYP2D6 (0.41) | CYP2D6GAAHTTLMNAALDH1A1 | |
| SCHEMBL21908632 | 0.73 | GAA (0.41) | SLC18A2GAA | |
| SCHEMBL21908629 | 0.73 | GAA (0.41) | SLC18A2GAA | |
| SCHEMBL21908619 | 0.73 | GAA (0.41) | SLC18A2GAA | |
| SCHEMBL26083170 | 0.72 | GAA (0.36) | SLC18A2GAA | |
| SCHEMBL26083020 | 0.72 | CYP2D6 (0.43) | CYP2D6GAAHTTLMNAMEN1 | |
| SCHEMBL21908620 | 0.72 | GAA (0.40) | SLC18A2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11782343-B2 | Resist composition and patterning process | HNRNPU, CBR1, CBR3 | SLC18A2 4310/4885EPHX2 2253/4885CYP2D6 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.